Anti-AMPK alpha 2 (phospho S345) antibody [EPMDAR6]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal AMPK alpha 2 phospho S345 antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
AMPK, AMPK2, PRKAA2, 5'-AMP-activated protein kinase catalytic subunit alpha-2, AMPK subunit alpha-2, Acetyl-CoA carboxylase kinase, Hydroxymethylglutaryl-CoA reductase kinase, ACACA kinase, HMGCR kinase
- WB
Unknown
Western blot - Anti-AMPK alpha 2 (phospho S345) antibody [EPMDAR6] (AB129081)
All lanes:
Western blot - Anti-AMPK alpha 2 (phospho S345) antibody [EPMDAR6] (ab129081) at 1/1000 dilution
Lane 1:
293T cell lysate, untreated at 10 µg
Lane 2:
293T cell lysate treated with Lambda Phosphatase at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 62 kDa
Observed band size: 62 kDa
false
Reactivity data
Product details
This antibody was developed as part of a collaboration with Jiyong Liang from the MD Anderson Cancer Center.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
npj metabolic health and disease 3:8 PubMed40052110
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature 643:201-209 PubMed39695235
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oleo science 72:929-938 PubMed37704444
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 21:1285-1295 PubMed35587258
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:8863-8876 PubMed34402182
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature metabolism 2:41-49 PubMed31993556
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 33:450-462.e10 PubMed29533785
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com